Effectiveness, Safety, and Costs of a Treatment Switch to Dolutegravir Plus Rilpivirine Dual Therapy in Treatment-Experienced HIV Patients

  1. Revuelta-Herrero, J.L.
  2. Chamorro-de-Vega, E.
  3. Rodríguez-González, C.G.
  4. Alonso, R.
  5. Herranz-Alonso, A.
  6. Sanjurjo-Sáez, M.
Journal:
Annals of Pharmacotherapy

ISSN: 1542-6270 1060-0280

Year of publication: 2018

Volume: 52

Issue: 1

Pages: 11-18

Type: Article

DOI: 10.1177/1060028017728294 GOOGLE SCHOLAR